Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
 |
The New Vision (Uganda) - September 13, 2001
John Eremu
The document code-named The Kampala Call To Action, noted that the major obstacles to preventing HIV infection of infants had been removed.
The statement pointed out that clinical trials had conclusively demonstrated that Zidovudine (AZT) given to HIV infected women during the later part of pregnancy, and for six weeks given to their infants along with formula feeding, could reduce HIV infection of infants by 67%.
"We call for immediate action for nations to implement countrywide programme to prevent HIV infection of infants, to identify HIV infected women, and to provide treatment for HIV infected children and mothers," the statement said.
"This action must include the creation of information programmes to raise international awareness of mother to child issues, the establishment of programmes to prevent prenatal care and treatment, acquisition and distribution of drugs to prevent prenatal HIV transmission, the elimination of laws that delay access to life-saving drugs and the procurement of funds that directly benefit children and women at risk of HIV infection," it added.
The four-day conference closes today.
010913
NV010906
Copyright © 2001 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .